Abstract
Acetylcholine (ACh) and two of its regulatory enzymes, namely, choline acetyltransferase (EC 2.3.1.6; choline acetylase, ChAc) and acetyl-cholinesterase [EC 3.1.1.7; acetylcholine acetyl hydrolase; red cell cholinesterase; (ChE); specific ChE; AChE] have important physiologic functions. Thus, for example, they are essential for neuromuscular and ganglionic transmission, interneuronal transmission in certain parts of the central nervous system (CNS) (83, 126, 215, 341a, 401) regulation of membrane permeability and perhaps also for axonal conduction (353, 358).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abderhalden, E., Paffrath, H., and Sickel, H., Beitrag zur Frage der Inkre-(Hormon) Wirkung des Cholins auf die motorischen Funktionen des Verdauungst kanales. II. Mitteilung. Pfluegers Arch. Gesamte Physiol. Menschen Tiere 207, 241 (1925).
Adams, D. H., The specificity of the human erythrocyte cholinesterase. Biochem. Biophys. Acta 3, 1 (1949).
Adams, R. C., Curare as aid to relaxation in anesthesia. Surg. Clin. North Am. 25, 735 (1945).
Adie, P. A., The reactivation of inhibited atropinesterase (EC 3–1–1–10). In “Proceedings of the Conference of Structure and Reactions of DFP Sensitive Enzymes” (E. Heilbronn, ed.), p. 167. Research Institute of National Defence, Stockholm, 1967.
Albanus, L., Järplid, B., and Sundwall, A., On the toxicity of TMB-4, a reactivator of inhibited cholinesterase. Biochem. Pharmacol. 12, 111 (1963).
Aldridge, W. N., The differentiation of true and pseudo cholinesterase by organophosphorus compounds. Biochem. J. 53, 62 (1953).
Alles, G. A., and Hawes, R. C., Cholinesterases in the blood of man, J. Biol. Chem.133, 375 (1940).
Allot, E. N., and Thompson, J. D., The familial incidence of low pseudocholinesterase level. Lancet2, 517 (1956).
Ambrus, C. M., and Ambrus, J. L., Effect of hyperthyroidism and treatment with thiouracil on cholinesterase levels. Z. Vitam.-, Horm.- Fermentforsch.2, 464 (1948).
Ambrus, P. S., and Ambrus, J. L., Effect of thyroid hormone and thyroidectomy on the synthesis of cholinesterases. Res. Commun. Chem. Pathol. Pharmacol. 2, 118 (1971).
Ambrus, M. S., and Black, J., Role of the pituitary and sex hormones in the synthesis of cholinesterases. Life Sci. 7, 279 (1968).
Ammon, R., and Meyer, H., Zur stereochemischen Spezifität der Acetylcholinesterase. Hoppe-Seyler’s Z. Physiol. Chem. 314, 198 (1959).
Ang. M., Fell, S., and Foldes, F. F., unpublished data (1974).
Angel, C. R., Mahin, D. T., Farris, R. D., Woodward, K. T., Yahas, J. M., and Storer, J. B., Heritability of plasma cholinesterase activity in inbred mouse strains. Science 156, 529 (1967).
Ansell, G. B., and Spanner, S., The origin and turnover of choline in the brain. In “Drugs and Cholinergic Mechanisms in the CSN” (E. Heilbronn and A. Winter, eds.), p. 143. Försvarets Forskningsanstalt, Stockholm, 1970.
Antopol, W., Schifrin, A., and Tuchuran, L., Decreased cholinesterase activity of serum in jaundice and in biliary disease. Proc. Soc. Exp. Biol. Med 38, 363 (1938).
Argent, D. S., Dennick, O. P., and Hofbiger, F., Prolonged apnoea after suxamethonium in man. Br. J. Anaesth. 27, 24 (1955).
Artusio, J. F., Jr., Riker, W. F., Jr., and Wescoe, W. C., Studies on the inter-relationship of certain cholinergic compounds. IV. Anticurare action in anesthetized man J. Pharmacol. Exp. Ther. 100, 227 (1950).
Auditore, J. V., and Sastry, B. V. R., Stereospecificity of erythrocyte acetylcholinesterase. Arch. Biochem. Biophys. 105, 506 (1964).
Auerbach, M. E., Davis, D. L., and Foldes, F. F., Micromethod for the colorimetric determination of tetracaine. Fed Proc., Fed Am. Soc. Exp. Biol. 11, 319 (1952).
Augustinsson, K. B., Cholinesterases; a study in comparative enzymology. Acta Physiol. Scand 15, Suppl. 52, 1 (1948).
Augustinsson, K. B., Substrate concentration and specificity of choline ester-splitting enzymes. Arch. Biochem. 23, 111 (1949).
Augustinsson, K. B., The normal variation of human blood cholinesterase activity. Acta Physiol. Scand 35, 40 (1955).
Augustinsson, K. B., Electrophoresis studies on blood plasma esterases. I. Mammalian plasmata. Acta Chem. Scand. 13, 571 (1959).
Augustinsson, K. B., Electrophoresis studies on blood plasma esterases. II. Avian, reptilian, amphibian and piscine plasmata. Acta Chem. Scand. 13, 1081 (1959).
Augustinsson, K. B., Multiple forms of esterase in vertebrate blood plasma. Ann. N.Y. Acad Sci. 94, 844 (1961).
Augustinsson, K. B., Classification and comparative enzymology of the cholinesterases and methods for their determination. In “Cholinesterases and Anti-Cholinesterase Agents” (G. B. Koelle, ed.), p. 89. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Augustinsson, K. B., The nature of an “anionic” site in butyrylcholinesterase compared with that of a similar site in acetylcholinesterase. Biochim. Biophys. Acta 128, 351 (1966).
Augustinsson, K. B., and Isacshen, T., The enzymatic hydrolysis of the ß-methyl derivatives of acetylcholine and acetylthiocholine. Acta Chem. Scand 11, 750 (1957).
Austin, L., and Berry, W. K., Two selective inhibitors of cholinesterase. Biochem. J. 54, 695 (1953).
Aven, M. H., Light, A., and Foldes, F. F., Hydrolysis of procaine in various mammalian plasmas. Fed Proc., Fed. Am. Soc. Exp. Biol. 12, 299 (1953).
Baart, N., Shanor, S. P., Van Hees, G. R., Erdos, E. G., and Foldes, F. F., Inhibitory effect of local anesthetics and their halogenated analogs on human plasma and red cell cholinesterase. Fed Proc., Fed Am. Soc. Exp. Biol. 15, 395 (1956).
Ballantyne, B., Histochemical and biochemical aspects of cholinesterase activity of adipose tissue. Arch. Int. Pharmacodyn. Ther. 173, 343 (1968).
Barker, L. A., Dowdall, M. J., Essman, W. B., and Whittaker, V. P., The compartmentation of acetylcholine in cholinergic nerve terminals. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 193. Försvarets Forskningsanstalt, Stockholm, 1970.
Barlow, R. B., “Introduction to Chemical Pharmacology,” 2nd ed. Methuen, London, 1964.
Barlow, R. B., and Dixon, O. D., Choline acetyltransferase in the nettle urtica dioica L. Biochem. J. 132, 15 (1973).
Barrnett, R. J., and Ball, E. G., Metabolic and ultrastructural changes induced in adipose tissue by insulin. J. Biophys. Biochem. Cytol. 8, 83 (1960).
Beckett, A. H., Vaughan, C. L., and Mitchard, M., Inhibition of the pseudocholinesterase in horse serum by some choline analogues. Biochem. Pharmacol 17, 1595 (1968).
Beleslin, D., and Polak, R. L., Depression by morphine and chloralose of acetylcholine release from the cat’s brain. J. Physiol. (London) 177, 411 (1965).
Berends, F., Reactiveringen “Veroudering” van Esterasen Geremd met Organische Fosforverbindengen. Thesis, University of Leiden (1964).
Berends, F., Stereospecificity in the reactivation and aging of butyryl-cholinesterase inhibited by organophosphates with an asymmetrical P-atom. Biochim. Biophys. Acta 81, 190 (1964).
Bergmann, F., Fine structure of the active surface of cholinesterase and the mechanism of enzymatic ester hydrolysis. Discuss. Faraday Soc. 20, 126 (1955).
Bergmann, F., The structure of the active surface of cholinesterases and the mechanism of their catalytic action in ester hydrolysis. Adv. Catal. 10, 131 (1958).
Bergmann, F., and Segal, R., The relationship of quaternary ammonium salts to the anionic sites of true and pseudo cholinesterase. Biochem. J. 58, 692 (1954).
Bergmann, F., and Segal, R., The characterization of tissue cholinesterases. Biochim. Biophys. Acta 16, 513 (1955).
Bergmann, F., Wurzel, M., and Shimoni, E., The enzymatic hydrolysis of acid anhydrides. Biochem. J. 55, 888 (1953).
Bergmann, F., Rimon, S., and Segal, R., Effect of pH on the activity of eel esterase towards different substrates. Biochem. J. 68, 493 (1958).
Berman, R., Wilson, I. B., and Nachmansohn, D., Choline acetylase specificity in relation to biological function. Biochim. Biophys. Acta 12, 315 (1953).
Berry, J. F., and Whittaker, V. P., The acyl-group specificity of choline acetylase. Biochem. J. 73, 447 (1959).
Berry, W. K., and Davis, D. R., Factors influencing the rate of “aging” of a series of alkyl methylphosphorylacetylcholinesterases. Biochem. J. 100, 572 (1966).
Beznak, A. B. L., Effect of acetylcholinesterase on the surviving frog heart. Nature (London) 181, 1190 (1958).
Bidstrup, P. L., Bonnell, J. A., and Beckett, A. G., Paralysis following poisoning by a new organic phosphorus insecticide (Mipafox). Br. Med J. 1, 1068 (1953).
Blaber, L. C., Studies on the mode of action of drugs which facilitate neuro-muscular transmission. Thesis, University of London (1962).
Borders, R. W., Stephen, C. R., Nowill, W. K., and Martin, R., The interrelationship of succinylcholine and the blood cholinesterases during anesthesia. Anesthesiology 16, 401 (1955).
Boume, J. G., Collier, H. O. J., and Somers, G. F., Succinylcholine (Succinoylcholine). Muscle relaxant of short duration. Lancet 1, 1225 (1952).
Brestkin, A. P., Ivanova, L. A., and Svechnikova, V. V., On the influence of choline on the rate of hydrolysis of acetylcholine under the action of bovine erythrocyte cholinesterase. Biokhimiya 31, 416 (1966).
Brodie, B. B., Distribution and fate of drugs. In “Absorption and Distribution of Drugs” (T. B. Binns, ed.), p. 199 Williams & Wilkins, Baltimore, Maryland, 1964.
Brodie, B. B., and Maickel, R. P., Comparative biochemistry of drug metabolism. In “Metabolic Factors Controlling Duration of Drug Action” (B. B. Brodie and E. G. Erdos, eds.), p. 299. Macmillan, New York, 1962.
Brown, B. B., and Bailey, L., Neuromuscular blocking action of gabacholine and congeners. Pharmacologist 2, 77 (1960).
Brown, B. B., and Bailey, L., personal communication (1961).
Browning, E. T., and Schulman, M. P., Acetylcholine synthesis by cortex slices of rat brain. J. Neurochem. 15, 1391 (1968).
Bull, G. B., Hebb, C. O., and Ratkovie, D., Choline acetylase in the human placenta at different stages of development. Nature (London) 190, 1202 (1961).
Bullock, T. H., Grundfest, H., Nachmansohn, D., and Rothenberg, M. A., Generality of the role of acetylcholine in nerve and muscle conduction. J. Neurophysiol. 10, 11 (1947).
Burgen, A. S., and Chipman, L. M., The location of cholinesterase in the central nervous system. Q. J. Exp. Physiol. Cogn. Med Sci. 37, 61 (1952).
Burnett, W., and Cohen, Y., Liver function after surgery: A study of 50 cases with particular reference to serum cholinesterase. Br. J. Anaesth. 72, 66 (1955).
Bush, G. H., The use of muscle relaxants in burnt children. Anaesthesia 19, 231 (1964).
Callahan, J. F., and Kruckenberg, S. M., Erythrocyte cholinesterase activity of domestic and laboratory animals: Normal levels for nine species. Am. J. Vet. Res. 28, 1509 (1967).
Cannavà, A., Azione in vitro degli alcaloidi fenantrenici dell’oppio e di alcuni loro derivati sulla attivita procainoesterasica del sangue. Arch. Ital. Sci. Farmacol. 3, 137 (1953).
Cavallito, C. J., Some speculations on the chemical nature of postjunctional membrane receptors. Fed Proc., Fed Am. Soc. Exp. Biol. 26, 1647 (1967).
Cavallito, C. J., Bonding characteristics of acetylcholine stimulants and antagonists and cholinergic receptors. Ann. N.Y. Acad. Sci. 144, 900 (1967).
Cavallito, C. J., Napoli, M. D., and O’Dell, T. B., Neuromuscular blocking activities of two short chain linked bisquaternary ammonium compounds. Arch. Int. Pharmacodyn. Then 149, 188 (1964).
Cavallito, C. J., White, H. L., and Yun, H. S., Inhibitors of choline acetyltransferase. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 97. Försvarets Forskningsanstalt, Stockholm, 1970.
Cavallito, C. J., Yun, H. S., Smith, J. C., and Foldes, F. F., Choline acetyltransferase inhibitors. Configurational and electronic features of styrylpyridine analogs. J. Med. Chem. 12, 134 (1969).
Cavallito, C. J., Yun, H. S., Kaplan, T., Smith, J. C., and Foldes, F. F., Choline acetyltransferase inhibitors. Dimensional and substituent effects among styrylpyridine analogs. J. Med Chem. 13, 221 (1970).
Cavallito, C. J., Yun, H. S., Edwards, M. L., and Foldes, F. F., Choline acetyltransferase inhibitors. Styrylpyridine analogs with nitrogen-atom modifications. J. Med Chem. 14, 130 (1971).
Celesia, G. G., and Jasper, J. J., Acetylcholine released from cerebral cortex in relation to state of activation. Neurology 16, 1053 (1966).
Chang, C. H., and Gaddum, J. H., Choline esters in tissue extracts. J. Physiol. (London) 79, 255 (1933).
Changeux, J. P., Ryter, A., and Leuzinger, W., On the association of tyrocidine with acetylcholinesterase. Proc. Natl. Acad Sci. U.S.A. 62, 986 (1969).
Chao, L. P., and Wolfgram, F., Purification and some properties of choline acetyltransferase (E.C.2.3.1.6) from bovine brain. J. Neurochem. 20, 1075 (1973).
Chase, J. F. A., and Tubbs, P. K., Specific inhibitors of camitine acetyltransferase and other acetyltransferases. Biochem. J. 100, 47P (1966).
Childs, A. F., Davies, D. R., Green, A. L., and Rutland, J. P., The reactivation by oximes and hydroxamic acids of cholinesterases inhibited by organo-phosphorus compounds. Br. J. Pharmaco1. Chemother. 10, 462 (1955).
Cimasoni, G., Inhibition of cholinesterases by fluoride in vitro. Biochem. J. 99, 133 (1966).
Clark, S. W., Glaubiger, G. A., and LaDu, B. N., Properties of plasma cholinesterase variants. Ann. N.Y. Acad Sci. 151, 710 (1968).
Clitherow, J. W., Mitchard, M., and Harper, N. J., The possible biological function of pseudocholinesterase. Nature (London) 199, 1000 (1963).
Coates, P. M., and Simpson, N. E., Genetic variations in human erythrocyte acetylcholinesterase. Science 175, 1466 (1972).
Cohen, J. A., Oosterbaan, R. A., and Warringa, M. G. P. J., The turnover number of aliesterase, pseudo-and true cholinesterase and the combination of these enzymes with diisopropylfluorophosphonate. Biochim. Biophys. Acta 18, 228 (1955).
Cohen, J. A., Oosterbaan, R. A., and Jansz, H. S., The chemical structure of the reactive group of esterases. Discuss. Faraday Soc. 20, 114 (1955).
Cohen, J. A., Oosterbaan, R. A., Jansz, H. S., and Berends, F., The active site of esterases. J. Cell. Physiol. 54, 231 (1959).
Cohen, J. A., and Oosterbaan, R. A., The active site of acetylcholinesterase and related esterases and its reactivity towards substrates and inhibitors. In “Cholinesterases and Anticholinesterase Agents” (G. B. Koelle, ed.), p. 299. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Cole, B. R., and Leadbeater, L., Estimation of the stability of dry horse serum cholinesterase by means of an accelerated storage test. J. Pharm. Pharmacol. 20, 48 (1968).
Collier, B., Discussion. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 173. Försvarets Forskningsanstalt, Stockholm, 1970.
Couteaux, R., Morphological and cytochemical observations on the postsynaptic membrane at motor end-plates and ganglionic synapses. Exp. Cell Res. Suppl. 5, 294 (1958).
Couteaux, R., and Taxi, J., Recherches histochimiques sur la distribution des activities cholinestérasiques au niveau de la synapse myoneurale. Arch. Anat. Microsc. Morphol. Exp. 41, 352 (1952).
Crossland, J., The significance of brain acetylcholine. J. Ment. Sci. 99, 247 (1953).
Crossland, J., Acetylcholine and the morphine abstinence syndrome. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 355. Försvarets Forskningsanstalt, Stockholm, 1970.
Curtis, D. R., Acetylcholine as a central transmitter. Can. J. Biochem. Physiol. 41, 2611 (1963).
Curtis, D. R., and Ryall, R. W., The excitation of Renshaw cells by cholinomimetics. Exp. Brain Res. 2, 49 (1966).
Dale, H. H., The action of certain esters and ethers of choline and their relation to muscarine. J. Pharmacol. Exp. Ther. 6, 147 (1914).
Daly, M. deB., and Wright, P. G., The effects of anticholinesterases upon peripheral vascular resistance in the dog. J. Physiol. (London) 133, 475 (1956).
Davies, R. O., Marton, A. V., and Kalow, W., The action of normal and atypical cholinesterase of human serum upon a series of esters of choline. Can. J. Biochem.38, 545 (1960).
Davis, R., and Koelle, G. B., Electron microscopic localization of acetylcholinesterase and nonspecific cholinesterase at the neuromuscular junction by the gold-thiocholine and gold-thiolacetic acid methods. J. Cell Biol.34, 157 (1967).
Denz, F. A., On the histochemistry of the myoneural junction. Br. J. Exp. Pathol.34, 329 (1953).
De Robertis, E., Morphological bases of synaptic processes and neurosecretion. In “Regional Neurochemistry” (S. S. Kety and J. Elkes, eds.), p. 248. Pergamon, Oxford, 1961.
De Robertis, E., Contribution of electronmicroscopy to some neuropharmacological problems. Biochem. Pharmacol. 9, 49 (1962).
De Robertis, E., and Bennett, H. S., Some features of the submicroscopic morphology of synapses in frog and earthworm. J. Biophys. Biochem. Cytol. 1, 47 (1955).
De Robertis, E., Pellegrino de Traldi, A., Rodrigues de Lores Amaiz, G., and Salganicoff, L., Cholinergic and non-cholinergic nerve endings in rat brain. I. Isolation and subcellular distribution of acetylcholine and acetylcholinesterase. J. Neurochem. 9, 23 (1962).
Dettbam, W. D., The acetylcholine system in peripheral nerve. Ann. N.Y. Acad Sci.144, 483 (1967).
Dixon, E. M., Variation in human cholinesterase activity. Diss. Abstr. 17, 2567 (1957).
Dixon, M., and Webb, E. C., “Enzymes,” 2nd ed. Academic Press, New York, 1964.
Dixon, W. E., On the mode of action of drugs. Med. Mag. (London) 16, 454 (1907).
Doenicke, A., Klinische Bedeutung der Pseudocholinesterase. In “Pseudocholinesterasen” (H. W. Goedde, A. Doenicke, and K. Altland, eds.), p. 128. Springer-Verlag, Heidelberg, Berlin, New York, 1967.
Doenicke, A., and Holle, F., Das Verhalten der Leberfunktion im postoperativen Schock. Fortschr. Med. 80, 253 (1962).
Doenicke, A., Gärtner, T., Kreutzberg, G., Remes, J., Spiess, W., and Steinbereithner, K., Kritische Betrachtungen über einen Fall ohne Serum-cholinesterase. Proc. Eur. Congr. Anaesthesiol., 1st, Vienna, Sept. –9, 1962 Vol. 2, p. 187 (1962).
Doenicke, A., Gürtner, T., Kreutzberg, G., Remes, J., Spiess, W., and Steinbereithner, K., Serum cholinesterase anenzymia: Report of a case confirmed by enzyme-histochemical examination of liver-biopsy specimen. Acta Anaesthesiol. Scand. 7, 59 (1963).
Donhoffer, A., Feinere lokalization verschiedener cholinesterasen der nervösen Darmgeflechte. Acta Morphol. Acad. Sci. Hung. 8, 375 (1959).
Eccles, J. C., Fatt, P., and Koketsu, K., Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motoneurones. J. Physiol. (London) 216, 524 (1954).
Ecobichon, D. J., and Israel, Y., Characterization of the esterases from electric tissue of electrophorus by starch-gel electrophoresis. Can. J. Biochem. 45, 1099 (1967).
Ecobichon, D. J., and Kalow, W., Some properties of the soluble esterases of liver. Can. J. Physiol. Pharmacol. 39, 1329 (1961).
Eldefrawi, M. E., Tripathi, R. K., and O’Brien, R. D., Acetylcholinesterase isoenzymes from the housefly brain. Biochem. Biophys. Acta 212, 308 (1970).
Ehrenpreis, S., Acetylcholine and nerve activity. Nature (London) 201, 887 (1964).
Ehrenpreis, S., Possible nature of the cholinergic receptor. Ann. N.Y. Acad Sci. 144, 720 (1967).
Ehrenpreis, S., Molecular aspects of cholinergic mechanisms. In “Drugs Affecting the Peripheral Nervous System” (A. Burger, ed.), Vol. 1, p. 1. Dekker, New York, 1968.
Ehrenpreis, S., Fleish, J. H., and Mittag, T. W., Approaches to the molecular nature of pharmacological receptors. Pharmacol. Rev. 21, 131 (1969).
Ehrenpreis, S., Hehir, R. M., and Mittag, T. W., Assay and properties of essential (junctional) cholinesterases of the rat diaphragm. In “Cholinergic Ligand Interactions” (D. J. Triggle, J. F. Moran, and E. A. Barnard, eds.), p. 67. Academic Press, New York, 1971.
Engelhard, N., and Erdmann, W. D., Ein neuer Reaktivator für durch alkyl-phosphatgehemmte Acetylcholinesterase. Kiln. Wochenschr. 41, 525 (1963).
Engelhard, N., and Erdmann, W. D., Beziehungen zwischen chemischer Struktur und Cholinesterase reaktivierender Wirksamkeit bei einer Reihe neuer bis-quartärer Pyridin4-aldoxime. Arzneim.-Forsch. 14, 870 (1964).
Engelhard, N., Prchal, K., and Nenner, M., Acetyicholinesterase. Angew. Chem. 6, 615 (1967).
Eränkö, O., and Teräväinen, H., Distribution of esterases in the myoneural junction of the striated muscle of the rat. J. Histochem. Cytochem. 15, 399 (1967).
Erdmann, W. D., Vergleichende Untersuchungen über das Penetrations-vermogen einiger Esterase-reaktivierender Oxime in das zentrale Nervensystem. Arzneim.- Fors ch. 15, 135 (1965).
Erdmann, W D, and Clarmann, M. V., Ein neuer Esterase-Reaktivator für die Behandlung von Vergiftungen mit Alkylphosphaten. Dtsch. Med Wochenschr. 88, 2201 (1963).
Erdos, E. G., Baart, N., Foldes, F. F., and Zsigmond, E. K., Activation of enzymatic hydrolysis of benzolcholine by tryptamine. Science 126, 1176 (1957).
Erdos, E. G., Foldes, F. F., Baart, N., and Shanor, S. P., Activating effect of tryptamine, benzylamine and histamine on plasma cholinesterase. Fed Proc., Fed Am. Soc. Exp. Biol. 16, 294 (1957).
Erdos, E. G., Baart, N., Shanor, S. P., and Foldes, F. F., The inhibitory effect of chlorpromazine and chlorpromazine sulfoxide on human cholinesterases. Arch. Int. Pharmacodyn. Ther. 117, 163 (1958).
Erdos, E. G., Foldes, F. F., Zsigmond, E. K., Baart, N., and Zwartz, J. A., Acceleration of plasma cholinesterase activity by quaternary ammonium salts. Science 128, 92 (1958).
Erdos, E. G., Foldes, F. F., Baart, N., Zsigmond, E. K., and Zwartz, J. A., The acceleratring effect of narcotic analgesics on the hydrolysis of aromatic substrates by human plasma cholinesterase. Biochem. Pharmacol. 297 (1959).
Evans, F. T., Gray, P. W. S., Lehmann, H., and Silke, E., Sensitivity to succinylcholine in relation to serum-cholinesterase. Lancet 1, 1229 (1952).
Everett, J. W., and Sawyer, C. H., Effects of castration and treatment with sex steroids on the synthesis of serum cholinesterase in the rat. Endocrinology 39, 323 (1946).
Faber, M., Relationship between serum choline esterase and serum albumin Acta Med. Scand 114, 72 (1943).
Fatt, P., and Katz, B., Spontaneous subthreshold activity at motor nerve endings. J. Physiol. (London) 117, 109 (1952).
Feldberg, W., Present views on mode of action of acetylcholine in central nervous system. Physiol. Rev. 25, 596 (1945).
Feldberg, W., and Vogt, M., Acetylcholine synthesis in different regions of the central nervous system. J. Physiol. (London) 107, 372 (1948).
Finster, M., personal communication (1974).
Foldes, F. F., Succinylmonochdline iodide: Its enzymatic hydrolysis and neuromuscular activity. Proc. Soc. Exp. Biol. Med 83, 187 (1953).
Foldes, F. F., “Muscle Relaxants in Anesthesiology,” p. 80. Thomas, Springfield, Illinois, 1957.
Foldes, F. F., The pharmacology of neuromuscular blocking agents in man. Clin. Pharmacol. Ther. 1, 345 (1960).
Foldes, F. F., The choice and mode of administration of relaxants. In “Muscle Relaxants” (F. F. Foldes, ed.), p. 1. Davis, Philadelphia, Pennsylvania, 1966.
Foldes, F. F., Adatok a Human Cholinesterasek és Choline Acetylase Biokémiajahoz. Orvostudomany 19, 15 (1968).
Foldes, F. F., Present concepts of the clinical use of muscle relaxants. Proc. Int. Anesth. Symp. 4th, Varna, Sept. 15–20, 1969 Vol. 4, p. 903 (1969).
Foldes, F. F., Presynaptic aspects of neuromuscular transmission and block. Anaesthesist 20, 6 (1971).
Foldes, F. F., and Aven, M. H., The hydrolysis of procaine and 2-chloroprocaine in spinal fluid. J. Pharmacol. Exp. Ther. 105, 259 (1952).
Foldes, F. F., and Deery, A., unpublished data (1972).
Foldes, F. F., and Deery, A., unpublished data (1974).
Foldes, F. F., and Foldes, V. M., a-amino fatty acid esters of choline: Interaction with ChE and neuromuscular activity in man. J. Pharmacol. Exp. Ther. 150, 220 (1965).
Foldes, F. F., and McNall, P. G., 2-chloroprocaine: A new local anesthetic agent. Anesthesiology 13, 287 (1952).
Foldes, F. F., and McNall, P. G., Toxicity of local anesthetics in man. Dent. Clin. North Am. July 257 (1961).
Foldes, F. F., and McNall, P. G., Myasthenia Gravis: A guide for anesthesiologists. Anesthesiology 23, 837 (1962).
Foldes, F. F., and Rhodes, D. H., Jr., The role of plasma cholinesterase in anesthesiology. Anesth. Analg. (Cleveland) 32, 305 (1953).
Foldes, F. F., and Smith, J. C., The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis. Ann. N. Y. Acad Sci. 135, 287 (1966).
Foldes, F. F., Abernethy, G. S., Cavallito, C. J., Hollinger, I., and Pan, T., Tetraquaternary neuromuscular blocking agents. Abstr. Sci. Pap. Annu. Meet. Am. Soc. Anesthesiol. p. 159 (1972).
Foldes, F. F., Ambrus, J. L., Back, N., Bardos, T. J., and Foldes, V. M., Relationship between the anticholinesterase activity and side effect liability of AB 132 in man. Fed. Proc., Fed. Am. Soc. Exp. Biol. 21, 335 (1962).
Foldes, F. F., Arai, T., Gentsch, H. H., and Zarday, Z., The influence of glucocorticoids on plasma cholinesterase. Proc. Soc. Exp. Biol. Med 146, 918 (1974).
Foldes, F. F., Aven, N. H., and Davis, D. L., The effect of preincubation on the inhibitory effect of neostigmine and dimethylcarbamate of (2-hydroxy-5-phenylbenzyl) trimethylammonium bromide (RO2–683) on the enzymatic hydrolysis of procaine. J. Pharmacol. Exp. Ther. 108, 330 (1953).
Foldes, F. F., Baart, N., Shanor, S. P., and Erdos, E. G., The inhibitory effect of neuromuscular blocking agents and their antagonists on human cholinesterases. Anesthesiology 18, 163 (1957).
Foldes, F. F., Baart, N., Shanor, S. P., and Erdos, E. G., The inhibitory effect of neuromuscular blocking agents and their antagonists on human cholinesterases. Atti Congr. Soc. Ital. Anestesiol. 11th, Venice, Sept. 12–15, 1958 p. 511 (1958).
Foldes, F. F., Colavincenzo, J. W., and Birch, J. H., Epidural anesthesia: A reappraisal (conclusions). Anesth. Analg. (Cleveland) 35, 89 (1956).
Foldes, F. F., Davidson, G. M., Duncalf, D., and Kuwabara, S., The intravenous toxicity of local anesthetic agents in man Clin. Pharmacol. Ther. 6, 328 (1965).
Foldes, F. F., Davis, D. L., and Shanor, S. P., Comparison of hydrolysis of acetylcholine, benzoylcholine, succinylcholine and procaine in human plasma. Fed Proc., Fed Am. Soc. Exp. Biol. 13, 354 (1954).
Foldes, F. F., Davis, D. L., Shanor, S. P., and van Hees, G. R., Hydrolysis of ester-type local anesthetics and their halogenated analogs by purified plasma cholinesterase. J. Ant Chem. Soc. 77, 5149 (1955).
Foldes, F. F., Erdos, E. G., Baart, N., Zwartz, J., and Zsigmond, E. K., Inhibition of human cholinesterases by narcotic analgesics and their antagonists. Arch Int. Pharmacodyn. Ther. 120, 286 (1959).
Foldes, F. F., Erdos, E. G., Zsigmond, E. K., and Zwartz, J. A., Reactivation of neostigmine inhibited human plasma cholinesterase. J. Pharmacol. Exp. Ther. 129, 394 (1960).
Foldes, F. F., Foldes, V. M., Smith, J. C., and Zsigmond, E. K., The relation between plasma cholinesterase and prolonged apnea caused by succinylcholine. Anesthesiology 24, 208 (1963).
Foldes, F. F., Foldes, V. M., and McNall, P. G., The use of echothiophate in myasthenia gravis. Clin. Pharmacol. Ther. 7, 620 (1966).
Foldes, F. F., Hillmer, N. R., Molloy, R. E., and Monte, A. B., Potentiation of the neuromuscular effect of succinylcholine by hexafluorenium. Anesthesiology 21, 50 (1960).
Foldes, F. F., Kepes, E. R., Kronfeld, P. P., and Shiffman, H. P., A rational approach to neuroleptanesthesia. Anesth. Analg. (Cleveland) 45, 642 (1966).
Foldes, F. F., McNall, P. G., Davis, D. L., Ellis, C. H., and Wnuck, A. L., Substrate competition between procaine and succinylcholine diiodide for plasma cholinesterase. Science 117, 383 (1953).
Foldes, F. F., Molloy, R. E., Zsigmond, E. K., and Zwartz, J. A., Hexafluorenium: Its anticholinesterase and neuromuscular activity. J. Pharmacol. Exp. Ther. 129, 400 (1960).
Foldes, F. F., Molloy, R. E., McNall, P. G., and Koukal, L. R., The comparison of the intravenous toxicity of local anesthetic agents in man. J. Am. Med Assoc. 172, 1493 (1960).
Foldes, F. F., Swerdlow, M., Lipschitz, E., and van Hees, G. R., Comparison of enzymatic hydrolysis of suxamethonium with their respiratory effects. Fed Proc., Fed Am. Soc. Exp. Biol. 14, 339 (1955).
Foldes, F. F., Swerdlow, M., Lipschitz, E., van Hees, G. R., and Shanor, S. P., Comparison of the respiratory effects of suxamethonium and suxethonium in man Anesthesiology 17, 559 (1956).
Foldes, F. F., van Hees, G. R., Shanor, S. P., and Baart, N., Interrelationship of suxamethonium, suxethonium and succinylmonocholine and human cholinesterase. Fed Proc., Fed. Am. Soc. Exp. Biol. 15, 422 (1956).
Foldes, F. F., van Hees, G. R., Davis, D. L., and Shnor, S. P., The structure-action relationship of urethane type cholinesterase inhibitors. J. Pharmacol. Exp. Ther. 122, 457 (1958).
Foldes, F. F., Zsigmond, E. K., Foldes, V. M., and Erdos, E. G., The distribution of acetylcholinesterase and butyrylcholinesterase in the human brain. J. Neurochem. 9, 559 (1962).
Foldes, V. M., Foldes, F. F., and Zsigmond, E. K., The in vivo and in vitro anti-cholinesterase effect of phospholine iodide in man. Fed Proc., Fed Am. Soc. Exp. Biol. 20, 2167 (1961).
Fonnum, F., The “compartmentation” of choline acetyltransferase within the synaptosome. BioChem. J. 103, 262 (1967).
Fonnum, F., Subcellular localization of choline acetyltransferase in brain. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 83. Försvarets Forskningsanstalt, Stockholm, 1970.
Forbath, A., Lehmann, H., and Silk, E., Prolonged apnea following succinylcholine. Lancet 2, 1067 (1953).
Fouts, J. R., Physiological impairment of drug metabolism. In “Metabolic Factors Controlling Duration of Drug Action” (B. B. Brodie and E. G. Erdos, eds.), p. 257. Macmillan, New York, 1962.
Fraser, P. J., Acceleration of the enzymatic hydrolysis of benzoylcholine. Br. J. Pharmacol. Chemother. 11, 7 (1956).
Friede, R. L., and Fleming, L. M., A comparison of cholinesterase distribution in the cerebellum of several species. J. Neurochem. 11, 1 (1964).
Friess, S. L., and Baldridge, H. D., The acetylcholinesterase surface. VI. Further studies with cyclic isomers as inhibitors and substrates. J. Am. Chem. Soc. 78, 2482 (1956).
Friess, S. L., and McCarville, W. J., Nature of the acetyl cholinesterase surface. II. The ring effect in enzymatic inhibition of the substituted ethylenediamine type. J. Am. Chem. Soc. 76, 2260 (1954).
Fuhner, H., Untersuchungen über die periphere Wirkung des Physostigmins. Arch. Exp. Pathol. Pharmakol. 82 205 (1917–1918).
Fuhner, H., Untersuchungen über den Synergismus von giften. W. Die Chemische Erregbarkeits-steigerung glatter Muskulatur. Arch. Exp. Pathol. Pharmakol. 82 51 (1917–1918).
Funke, A., Bagot, J., and Depierre, F., Anticholinestérasiques. I. Synthèse de diphénoxyalcanes porteurs d’une ou deux fonctions phénoliques libres. C. R. Hebd. Seances Acad. Sci. (Paris) 239, 329 (1954).
Funnel, H., and Oliver, W. T., Proposed physiological function for plasma cholinesterase. Nature (London) 208, 689 (1965).
Gerebtzoff, M. A., “Cholinesterase. A Histochemical Contribution to the Solution of Some Functional Problems.” Pergamon, Oxford, 1959.
Giacobini, E., and Holmstedt, B., Cholinesterase content of certent of certain regions of the spinal cord as judged by histochemical and Cartesian diver technique. Acta Physiol. Scand 42, 12 (1958).
Giarman, N. J., and Pepen, G., Drug-induced changes in brain acetylcholine. Br. J. Pharmacol. Chemother. 19, 226 (1962).
Glick, D., Studies on the specificity of choline esterase. J. Biol. Chem. 125, 729 (1938).
Glick, D., Some additional observations on the specificity of choline esterase. J. Biol. Chem. 137, 357 (1941).
Glover, V. A. S., and Potter, L. T., Purification and properties of choline acetyltransf erase from ox brain striate nuclei. J. Neurochem. 18, 571 (1971).
Goedde, H. W., and Altland, K., Biochemic und Genetike der Pseudocholinesterasen. In “Cholinesterasen: Pharmakogenetik, Biochemic Klinik” (H. W. Goedde, A. Doenicke, and K. Altland, eds.), p. 1. Springer-Verlag, Berlin, Heidelberg, and New York, 1967.
Goedde, H. W., and Baitsch, H., Nomenclature of pseudocholinesterase polymorphism Br. Med. J. 2, 310 (1964).
Goedde, H. W., and Baitsch, H., On nomenclature of pseudocholinesterse polymorphism. Acta Genet. Stat. Med. 14, 366 (1964).
Goedde, H. W., and Fuss, W., Differenzierung von Pseudocholinesterase-Varienten im Diffusionstest. Klin. Wochenschr. 42, 286 (1964).
Goedde, H. W., and Fuss, W., Untersuchungen zur Phylogenetic der Pseudo-cholinesterasen. Humangenetik 1, 126 (1964).
Goedde, H. W., Altland, K., and Scholler, L., Pharmakogenetische Reaktion auf Succinyldicholin: Therapie der verlängerten Apnoe. Med Klin. (Munick) 62, 1631 (1967).
Goedde, H. W., Altland, K., and Schloot, W., Therapy of prolonged apnea after suxamethonium with purified pseudocholinesterase: New data on kinetics of the hydrolysis of succinyldicholine and succinylmonocholine and further data on Nacetyltransf erase-polymorphism. Ann. N.Y. Acad. Sci. 151, 742 (1968).
Goedde, H. W., Gehring, D., and Hofmann, R. A., On the problem of a “silent gene” in pseudocholinesterase polymorphism. Biocheim. Biophys. Acta 107, 391 (1965).
Goedde, H. W., Gehring, D., and Hofman, R. A., Biochemische Untersuchungen zur Frage der Existenz eines “siltent gene” in Polymorphismus der Pseudo-cholinesterasen. Humangenetik 1, 607 (1965).
Goedde, H. W., Held, K. R., and Altland, K., Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol. Pharmacol. 4, 274 (1968).
Gold, A. J., Weller, J. M., and Freeman, G., Metabolic and acid-base changes following acute cholinesterase inhibition. Am. J. Physiol. 188, 321 (1957).
Goldberg, A. M., and McCaman, R. E., A quantitative michrochemical study of choline acetyltransferase in the cerebellum of several species. Life Sci. 6, 1493 (1967).
Goutier-Pirotte, M., and Gerebtzoff, M. A., Acetylcholinesterase in the guinea pig placenta; initial results of histochemical and biochemical research. Arch. Int. Physiol. Biochim. 63, 445 (1955).
Graig, F. A., and Foldes, F. F., unpublished data (1969).
Gray, E. G., and Whittaker, V. P., The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96, 79 (1962).
Green, A. L., and Nicholls, J. D., The reactivation of phosphorylated chymotrypsin. Biochem. J. 72, 70 (1959).
Grob, D., and Johns, R. J., Use of oximes in the treatment of intoxication by anti-cholinesterase compounds in normal subjects. Am. J. Med 24, 497 (1958).
Grob, D., and Johns, R. J., Use of oximes in the treatment of intoxication by anti-cholinesterase compounds in patients with myasthenia gravis. Am. J. Med 24, 512 (1958).
Gronert, G. A., Dotin, L. N., Ritchey, C. R., and Mason, A. D., Jr., Succinyl-choline-induced hyperkalemia in burned patients. II. Anesth. Analg. (Cleveland) 48, 958 (1969).
Gurtner, T., Kreutzberg, G., and Doenicke, A., Comparative studies on cholinesterase activity in serum and liver cells. Acta Anaesthesiol. Scand7, 69 (1963).
Hardegg, W., Rieken, E., and Schmalz, H., Uber die Kinetik der Benzoyl-cholinspaltung durch die Serum-Cholinesterase und ihre Beeinflussung durch Cholin. Biochem. Z.324, 115 (1953).
Harris, H., and Whittaker, M., Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes. Nature (London) 191, 496 (1961).
Harris, H., Hopkinson, D. A., and Robson, E. B., Two-dimensional electrophoresis of pseudocholinesterase components in human serum. Nature (London) 196, 1296 (1962).
Harris, H., Hopkinson, D. A., Robson, E. B., and Whittaker, M., Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann. Hum. Genet. 26, 359 (1963).
Harris, H., Hopkinson, D. A., and Robson, E. B., Two-dimensional electrophoresis of pseudocholinesterase components in human serum. Nature (London) 196, 1296 (1962).
Harris, L. W., Fleisher, J. H., Clark, J., and Cliff, W. J., Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by saran. Science 154, 404 (1966).
Haupt, H., Heide, K., Zwisler, O., and Schwick, H. G., Isolierung und physikalisch-chemische charakterisierung der Cholinesterase aus Human serum. Blut 14, 65 (1966).
Hazard, R., Comec, A., and Pignard, P., La dihydrooxycodéinone activateur de la procainestérase. C. R. Seances Soc. Biol. Ses Fil. 144, 356 (1950).
Hazard, R., Uriel, J., and Larno, S., Apparente identité de la cholinesterase et de la procainesterase sériques d’origine humaine. J. Physiol. (Paris) 59, 5 (1967).
Heath, D. F., “Organophosphorus Poisons-Anticholinesterases and Related Compounds,” 1st ed. Pergamon, Oxford, 1961.
Heath, D. F., The toxic action of some phosphorus anticholinesterases with cationic groups. Biochem. Pharmacol. 6, 244 (1961).
Hebb, C., Formation, storage, and liberation of acetylcholine. In “Cholinesterases and Anticholinesterase Agents” (G. B. Koelle, ed.), p. 55. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Hebb, C., Biosynthesis of acetylcholine in nervous tissue. Physiol. Rev. 52, 918 (1972).
Hebb, C. O., and Smallman, B N, Intracellular distribution of choline acetylase. J. Physiol. (London) 134, 385 (1956).
Hebb, C. O., and Waites, G. M., Choline acetylase in antero-and retrograde degeneration of a cholinergie neuron. J. Physiol. (London) 132, 667 (1956).
Hebb, C. O., and Whittaker, V. P., Cellular distributions of acetylcholine and choline acetylase. J. Physiol. (London) 142, 187 (1958).
Heilbronn, E., Purification of cholinesterase from horse serum. Biochim. Biophys. Acta 58, 222 (1962).
Heilbronn, E., In vitro reactivation and “ageing” of tabun-inhibited blood cholinesterases. Studies with N-methyl pyridinium-2-aldoxime methane sulphonate and N,N’-trimethylene bis (pyridinium-4-aldoxime) dibromide. Biochem. Pharmacol. 12, 25 (1963).
Heilbronn, E., Phosphorylated cholinesterases, their formation, reactions and induced hydrolysis. Sven. Kern. Tidskr.77, 11 (1965).
Heilbronn, E., and Tolagen, B., Toxogenin in satin, soman and tabun poisoning. Biochem. Pharmacol. 14, 73 (1965).
Heinecker, R., and Mayer, I., Das Verhalten der Serumcholinesterase nach Myokard-infarkt. Klin. Wochenschr. 35, 340 (1957).
Hemsworth, B. A., and Foldes, F. F., Preliminary pharmacological screening of styrylpyridine choline acetyltransferase inhibitors. Eur. J. Pharmacol. 11, 187 (1970).
Herschberg, A. D., and Frommel, F., Cholinesterase sérique et glandes sexuelles. Annea Endocrinol. 9, 117 (1948).
Hirano, A., and Dembitzer, H. M., Cerebellar alterations in the Weaver mouse. J. Cell Biol. 56, 478 (1973).
Hobbiger, F., Effect of nicotinhydroxamic acid methiodide on human plasma cholinesterase inhibited by organophosphate containing a dialkylphosphate group. Br. J. Pharmacol. Chemother. 10, 356 (1955).
Hobbiger, F., Chemical reactivation of phosphorylated human and bovine true cholinesterase. Br. J. Pharmacol. Chemother. 11, 295 (1956).
Hobbiger, F., The inhibition of organophosphorus compounds and its reversal. Proc. R. Soc. Med 54, 403 (1961).
Hobbiger, F., and Vojvodic, V., The reactivating and antidotal actions of N,N’-trimethylenebis(pyridinium-4-aldoxime)(TMB-4) and N,N’ -oxydimethyl-enebis(pyridinium-4aldoxime) (toxogenin) with particular reference to their effect on phosphorylated acetylcholinesterase in brain. Biochem. Pharmacol. 15, 1677 (1966).
Hobbiger, F., O’Sullivan, D. G., and Sadler, P. W., New potent reactivators of acetocholinesterase inhibited by tetraethyl pyrophosphate. Nature (London) 182, 1672 (1958).
Hofstee, B. H. J., Spectrophotometric determinations of esterases. Science 114, 128 (1951).
Hokin, L. E., and Hokin, M. R., The role of phosphatidic acid and phosphoionositide in transmembrane transport elicited by acetylcholine and other humoral agents. Int. Rev. Neurobiol. 2, 99 (1960).
Hokin, M. R., Hokin, L. E., and Shelp, W. D., The effects of acetylcholine on the turnover of phosphatidic acid and phosphoinositide in sympathetic ganglia, and in various parts of the central nervous system in vitro. J. Gen. Physiol. 44, 217 (1960).
Holle, F., and Doenicke, A., Cholinesterase in der Chirurgie. Ergeb. Chir. Orthop. 43, 77 (1961).
Holmstedt, B., A modification of the thiocholine method for the determination of cholinesterase. I. Biochemical evaluations of selective inhibitors. Acta Physiol. Scand 40, 322 (1957).
Hoskin, F. C. G., Sterospecificity in the reactions of acetylcholinesterase. Proc. Soc. Exp. Biol. Med. 113, 320 (1963).
Hoskin, F. C. G., and Trick, G. S., Stereospecificity in the enzymatic hydrolysis of tabun and acetyl-methylcholine chloride. Can. J. Biochem. Physiol. 33, 963 (1955).
Hunt, R., Note on a blood pressure lowering body in the suprarenal gland. Am J. Physiol. 3, 18 (1900).
Hunt, R., Further observations on the blood-pressure-lowering bodies in extracts of the suprarenal glands. Am. J. Physiol. 5, 6 (1901).
Hunt, R., Some physiological actions of the homocholins and of some of their derivatives. J. Pharmacol. Exp. Ther. 6, 477 (1915).
Hunt, R., and Taveau, R. DeM., On the physiological action of certain cholin derivatives and new methods for detecting cholin. Br. Med. J. 2, 1788 (1906).
Hunt, R., and Taveau, R. DeM., The effects of a number of derivatives of choline and analogous compounds on the blood pressure. U. S. Public Health Mar. Hosp. Serv. Hyg. Lab. Bull. 73, 1 (1911).
Hunter, A. R., Tension: A new anticurare agent. Br. J. Anaesth. 24, 175 (1952).
Irwin, R. L., and Hein, M. M., The substrate specificity of atypical cholinesterase in relation to phenotypes. Biochem. Pharmacol.15, 145 (1966).
Jaffe, M. J., Evidence for the regulation of phytochrome-mediated processes in bean roots by the neurohumor, acetylcholine. Plant Physiol. 46, 768 (1970).
Jandorf, B. J., Michel, H. O., Schaffer, N. K., Egan, R., and Summerson, W. H., The mechanism of reaction between esterases and phosphorus-containing anti-esterases. Discuss. Faraday Soc. 20, 134 (1955).
Jandorf, B. J., Crowell, E. A., and Levin, A. P., Role of hydroxamic acids in prevention and reversal of cholinesterase inactivation by DFP and sann. Fed Proc., Fed. Am. Soc. Exp. Biol. 14, 231 (1955).
Jansz, H. S., and Cohen, J. A., Pseudocholinesterase from horse serum. I. Purification and properties of the enzyme. Biochim. Biophys. Acta 56, 531 (1962).
Jansz, H S, Oosterbaan, R. A., Berends, F., and Cohen, J. A., Studies on the active site of esterases. In “Molecular Basis of Enzyme Action and Inhibition” (P. A. E. Desnuelle, ed.), 1st ed., p. 45. Pergamon, Oxford, 1963.
Jenkins, T., Balinsky, D., and Patient, D. W., Cholinesterase in plasma: First reported absence in the Bantu: Half-life determination. Science 156, 1748 (1967).
Jondorf, W. R., Maickel, R. P., and Brodie, B. B., Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1, 352 (1959).
Jung, M. J., and Belleau, B., Purification and fractionation of acetyl-cholinesterase into subspecies by affinity chromatography on a d-tubocurarine-sepharose column. Mol. Pharmacol. 6, 589 (1972).
Juul, P., Human plasma cholinesterase isoenzymes. Clin. China Acta 19, 205 (1968).
Kabachnik, M. I., Brestkin, A. P., Godovikov, N. N., Michelson, M. J., Rozengart, E. V., and Rozengart, V. I., Hydrophobic areas on the active surface of cholinesterases. Pharmacol. Rev. 22, 355 (1970).
Kaita, A. A., and Goldberg, A. M., Control of acetylcholine synthesis-the inhibition of choline acetyltransferase by acetylcholine. J. Neurochem. 16, 1185 (1969).
Kalow, W., Hydrolysis of local anesthetics by human serum cholinesterase. J. Pharmacol. Exp. Ther. 104, 122 (1952).
Kalow, W., Familial incidence of low pseudocholinesterase level. Lancet 2, 576 (1956).
Kalow, W., Cholinesterase types. Biochem. Hum. Genet., Ciba Found Symp. 1959p. 39 (1959).
Kalow, W., and Davies, R. O., The activity of various esterase inhibitors towards atypical human serum cholinesterase. Biochem. Pharmacol. 1, 183 (1959).
Kalow, W., and Genest, K., Method for detection of atypical forms of human serum cholinesterases: Determination of dibucaine numbers. Can. J. Biochem. Physiol. 35, 339 (1957).
Kalow, W., and Gunn, D. R., Some statistical data on atypical cholinesterase of human serum. Ann. Hum. Genet. 23, 239 (1959).
Kalow, W., and Lindsay, H., Abnormal behavior of human serum cholinesterase. J. Pharmacol. Exp. Ther. 116, 34 (1956).
Kalow, W., and Staron, N., On distribution and inheritance of atypical forms of human serum cholinesterase as indicated by dibucaine numbers. Can. J. Biochem. Physiol. 35, 1305 (1957).
Kalow, W., Genest, K., and Staron, N., Qualitative variation of serum cholinesterase activity in man as defined by dibucaine numbers. Fed Proc., Fed Am. Soc. Exp. Biol. 15, 444 (1956).
Kamijo, K., and Koelle, G. B., The histochemical localization of specific cholinesterase in the conduction system of beef heart. J. Pharmacol. Exp. Ther. 113, 30 (1955).
Kaplan, E., Herz, F., and Hsu, K. S., Erythrocyte acetylcholinesterase activity in ABO hemolytic disease of the newborn. Pediatrics33, 205 (1964).
Karczmar, A. G., Ontogenesis of cholinesterases. In “Cholinesterases and Anti-cholinesterase Agents” (G. B. Koelle, ed.), p. 129. Springer-Verlag, Berlin, 1963.
Karczmar, A. G., Discussion of paper by Nachmansohn, D. Molecular forces controlling bioelectric currents in membranes. In “Nerve as a Tissue” (K. Rodahi, ed.), p. 273. Harper (Hoeber), New York, 1966.
Karczmar, A. G., Central cholinergic pathways and their behavioral implications. In “Principles of Psychopharmacology” (W. G. Clark et al., eds.), p. 57. Academic Press, New York, 1970.
Karczmar, A. G., History of the research with anticholinesterase agents. In “Anti-cholinesterase Agents” (A. G. Karczmar, ed.), Int. Encycl. Pharmacol. Ther., Sect. 13, Vol. I, p. 1. Pergamon, Oxford, New York, 1970.
Karlin, A., The association of acetylcholinesterase and membrane in subcellular fractions of the electric tissue of electrophorus. J. Cell Biol. 25, 159 (1965).
Karlin, A., Chemical distinctions between acetylcholinesterase and the acetylcholine receptor. Biochim. Biophys. Acta 139, 358 (1967).
Karlin, A., and Winnik, M., Reduction and specific alkylation of the receptor for acetylcholine. Proc. Natl. Acad Sci. U.S.A. 60, 668 (1968).
Kasa, P., and Csernovsky, E., Electron microscopic localization of acetylcholinesterase in the superior cervical ganglion of the rat. Acta Histochem. 28, 274 (1967).
Kasa, P., and Csillik, B., Electron microscopic localization of cholinesterase by a copper-lead-thiocholine technique. J. Neurochem. 13, 1345 (1966).
Kasa, P., Mann, S. P., and Hebb, C., Localization of choline acetyltransferase. Nature (London) 226, 812 (1970).
Kato, G., Acetylcholinesterase I. A study by nuclear magnetic resonance of the binding of inhibitors to the enzyme. Mol. Pharmacol. 8, 575 (1972).
Kato, G., Acetylcholinesterase II. A study by nuclear magnetic resonance of the acceleration of acetylcholinesterase by atropine and inhibition by eserine. Mol. Pharmacol. 8, 582 (1972).
Katz, B., “Nerve, Muscle and Synapse.” McGraw-Hill, New York, 1966.
Kaulla, von K., and Holmes, J. H., Changes following anticholinesterase exposures. Blood coagulation studies. Arch. Environ. Health 2, 168 (1961).
Klein, H., Gärtner, K., and Günther, R., Die Variante C5 der Cholinesterasen des Serums. Dtsch. Z. Gesamte Gerichtl. Med 61, 137 (1967).
Kloot, W. G. Van der, The effect of enzyme inhibitors on the resting potential and on the ion distribution of the sartorius muscle of the frog. J. Gen. Physiol. 41, 879 (1958).
Klupp, H., and Kraupp, O., Uber die freisetzung von Kalium aus der Muskalatus unter der Einwirkung einiger Muskelrelaxantien. Arch. Int. Pharmacodyn. Ther. 98, 340 (1954).
Koelle, G. B., The histochemical differentiation of types of cholinesterases and their localizations in tissues of the cat. J. Pharmacol. Exp. Ther. 100, 158 (1950).
Koelle, G. B., The elimination of enzymatic diffusion artifacts in the histochemical localization of cholinesterases and a survey of their distributions. J. Pharmacol. Exp. Ther. 103, 153 (1951).
Koelle, G. B., ed., “Cholinesterases and Anticholinesterase Agents.” Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Koelle, G. B., Cytological distributions and physiological functions of Cholinesterases. In “Cholinesterases and Anticholinesterase Agents” (G. B. Koelle, ed.), p. 187. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Koelle, G. B., The neurohumoral theory. In “Nerve as a Tissue” (K. Rodahl, ed.), p. 287. Harper (Hoeber), New York, 1966.
Koelle, G. B., Part I. Correlations between ultrastructures, cytochemistry and function at the synapse. Current concepts of synaptic structure and function. Ann. N. Y. Acad Sci. 183, 5 (1971).
Koelle, G. B., Acetylcholine-current status in physiology, pharmacology and medicine. N. Engl. J. Med. 286, 1086 (1972).
Koelle, G. B., Davis, R., and Smyrl, E. G., New findings concerning the localization by electron microscopy of acetylcholinesterase in autonomic ganglia. Prog. Brain Res. 34, 371 (1971).
Koelle, W. A., and Koelle, G. B., The localization of external or functional acetylcholinesterase at the synapses of autonomic ganglia. J. Pharmacol. Exp. Ther. 126, 1 (1959).
Koenig, E., and Koelle, G. B., Acetyicholinesterase in cholinergic neurons following irreversible inactivation. J. Neurochem.8, 169 (1961).
Kondritzer, A. A., Zvirblis, P., Goodman, A., and Paplanus, S. H., Blood plasma levels and elimination of salts of 2-PAM in man after oral administration. J. Pharm. Sci. 57, 1142 (1968).
Korolkovas, A., “Essentials of Molecular Pharmacology. Background for Drug Design” p. 205. Wiley (Interscience), New York, 1970.
Köver, A., Kónya, L., Kovacs, L., and Szöör, A., Positive isotropic action of cholinesterase on the hypodynamic frog heart. Acta Physiol. Acad Sci. Hung. 22, 145 (1962).
Kramer, T., Preliminary report on the innervation of the embryonic chick heart. Anat. Rec. 106, 210 (1950).
Krupka, R. M., Fluoride inhibition of acetylcholinesterase. Mol. Pharmacol. 2, 558 (1966).
Krupka, R. M., and Laidler, K. J., Molecular mechanisms for hydrolytic enzyme action. I. Apparent non-competitive inhibition, with special reference to acetylcholinesterase. II. Inhibition of acetylcholinesterase by excess substrate. III. A general mechanism for the inhibition of acetylcholinesterase. IV. The structure of the active center and the reaction mechanism. J. Am. Chem. Soc.83, 1445 (1961).
Kupfer, C., and Koelle, G. B., A histochemical study of cholinesterase during formation of the motor and plate of the albino rat. J. Exp. Zool. 116, 397 (1951).
Kurokawa, M., Machijama, Y., and Kato, M., Distribution of acetylcholine in the brain during various states of activity. J. Neurochem. 10, 341 (1963).
Lakos, T., Csinady, L., and Kovacs, T., Die Rolle der Cholinesterase im Kationentrsnsport des muskels. Acta Physiol. Acad. Sci. Hung. 16, Suppl. 44 (1959).
La Motta, R. V., McComb, R. B., Noll, C. R., Jr., Wetstone, H. J., and Reinfrank, R. F., Multiple forms of serum cholinesterase. Arch. Biochem. Biophys. 124, 299 (1968).
Lawler, H. C., Turnover time of acetylcholinesterase. J. Biol. Chem. 236, 2296 (1961).
Lehmann, H., and Liddell, J., Genetical variants of human serum pseudocholinesterase. Prog. Med. Genet. 3, 75 (1964).
Lehmann, H., and Ryan, E., The familial incidence of low pseudocholinesterase level. Lancet 2, 124 (1956).
Lehmann, H., Liddell, J., Blackwell, B., O’Connor, D. C., and Daws, A. V., Two further serum pseudocholinesterase phenotypes as causes of suxamethonium apnoea. Br. Med J. 1, 1116 (1963).
Lehmann, H., Patson, V., and Ryan, E., The inheritance of an idiopathic low plasma pseudocholinesterase level. J. Clin. Pathol. 11, 554 (1958).
Lehmann, H., Silk, E., and Liddell, J., Pseudo-cholinesterase. Br. Med. Bull17, 230 (1961).
Leopold, I. H., and Krishna, N., Local use of anticholinesterase agents in ocular therapy. In “Cholinesterases and Anticholinesterase Agents” (G. B. Koelle, ed.), p. 1051. Springer-Verlag, Berlin, 1963.
Leuzinger, W., Structure and function of acetylcholinesterases. Prog. Brain Res. 31, 241 (1969).
Leuzinger, W., The number of catalytic sites in acetylcholinesterase. Biochem. J. 123, 139 (1971).
Leuzinger, W., and Baker, A. L., Acetylcholinesterase, I. Large scale purification, homogeneity and amino acid analysis. Proc. Natl. Acad Sci. U. S. A.57, 446 (1967).
Leuzinger, W., Baker, A. L., and Cauvin, E., Acetylcholinesterase. II. Crystallization, absorption spectra, isoionic point. Proc. Natl. Acad Sci. U. S. A. 59, 620 (1968).
Leuzinger, W., Goldberg, M., and Cauvin, E., Molecular properties of acetylcholinesterases. J. Mol. Biot. 40, 217 (1969).
Leuzinger, W., Goldberg, M., and Cauvin, E., Molecular properties of acetyl-cholinesterase. J. Mol. Biol. 40, 365 (1969).
Leuzinger, W., and Schneider, M., Acetylcholine-induced excitation on bilayers. Experientia 28, 256 (1972).
Levine, M. G., and Hoyt, R. E., Serum cholinesterase in some pathological conditions. Proc. Soc. Exp. Biol. Med 70, 50 (1949).
Levine, M. G., and Hoyt, R. E., The relationship between human serum cholinesterase and serum albumin. Science 111, 286 (1950).
Lewis, P. R., and Shute, C. C. D., The distribution of cholinesterase in cholinergie neurons demonstrated with the electron microscope. J. Cell Sci. 1, 381 (1966).
Liddell, J., Lehmann, H., and Silk, E., A “silent” pseudocholinesterase gene. Nature (London) 193, 561 (1962).
Liddell, J., Lehmann, H., Davies, D., and Sharih, A., Physical separation of pseudo-cholinesterase variants in human serum. Lancet 1, 463 (1962).
Liddell, J., Newman, G. E., and Brown, D. F., A pseudocholinesterase variant in human tissues. Nature (London) 198, 1090 (1963).
Loewi, O., Uber humorale übertragbarkeit der Herzenervenwirkung. I. Mitteilung. Pfluegers Arch. Gesamte Physiol…Menschen Tiere 189, 239 (1921).
Loewi, O., and Mansfield, G., Uber den Wirkungsmodus des Physostigmins. Arch. Exp. Pathol. Pharmakol. 62, 180 (1910).
Loewi, O., and Navratil, E., Uber humorale Ubertragbarkeit der Herzenervenwirkung. X. Uber das Schicksal des Vagusstoffes. Pfluegers Arch. Gesamte Physiol. Menschen Tiere 214, 678 (1926).
Long, J. P., Structure-activity relationships of the reversible anti-cholinesterase agents. In “Cholinesterases and Anti-cholinesterase Agents” (G. B. Koelle, ed.), p. 374. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Lüttringhaus, A., and Hagedorn, I., Quartare Hydroxyiminomethylpyridiniumsalze. Das Dichlorid des Bis-[4-hydroxylminomethylpyridinium-(1)-methyl]-ather (“Lüth 6”) ein neuer Reaktivator der durch organische Phosphorsaureester gehemten Acetyl-cholinesterase. Arzneim-Forsch 14, 1 (1961).
Macfarlane, D. W., Pelikan, E. W., and Unna, K. R., Evaluation of curarizing drugs in man V Antagonism to curarizing effects of d-tubocurarine by neostigmine m-hydroxy phenyltrimethylammonium and m-hydroxy phenylethyldimethylammonium. J. Pharmacol. Exp. Ther. 100, 382 (1950).
McIsaac, R. J., and Koelle, G. B., Comparison of the effects of inhibition of external, internal, and total acetylcholinesterase upon ganglionic transmission. J. Pharmacol. Exp. Ther. 126, 9 (1959).
Maier, E. H., and Fischer, R., Serum-cholinesterase-aktivitat und Lebermorphologie. Klin. Wochenschr. 32, 566 (1954).
Main, A. R., Affinity and phosphorylation constants for the inhibition of esterases by organophosphates. Science 144, 992 (1964).
Malmström, B. G., Levin, O., and Boman, H. G.; Chromatrography of human serum cholinesterase. Acta Chem. Scand. 10, 1077 (1956).
Malthe-Sørensen, D., and Fonnum, F., Multiple forms of choline acetyltransferase from rat brain. Nature (London) New Biol. 229, 127 (1971).
Malthe-Sirenson, D., and Fortnum, F., Multiple forms of choline acetyltransferase in several species demonstrated by isoelectric focusing. Biochem. J. 127, 229 (1972).
Manner, G., Foldes, F. F., Kuleba, M., and Decry, A. M., Morphine tolerance in a human neuroblastoma line: Changes in choline acetylase and cholinesterase activities. Experientia 30, 137 (1974).
Manner, G., Hirano, A., Dembitzer, H. M., and Foldes, F. F., unpublished data.
Markert, C. L., and Miller, F., Multiple forms of enzymes: Tissue, ontogenetic and species specific patterns. Proc. Natl. Acad Sci. U. S. A. 45, 753 (1959).
Massoulié, J., and Rieger, F., L’acétylcholinésterase des organes électriques de poissons (torpille et gymnote); complexes membranaires Eur. J. Biochem. 11, 441 (1969).
Mayrhofer, O., Die Nebenwirkungen des Succinylcholins und ihre Verhuetung. Curare Curare-like Agents, Proc. Int. Symp.1958 p. 376.
McCance, R. A., Hutchinson, A. O., Dean, R. F. A., and Jones, P. E. H., The cholinesterase activity of the serum of newborn animals and of colostrum. Biochem. J. 45, 493 (1949).
Mendel, B., and Rudney, H., Studies on cholinesterase; cholinesterase and pseudo-cholinesterase. Biochem. J. 37, 59 (1943).
Mendel, B., Mundell, D. B., and Rudney, H., Studies on cholinesterase. III. Specific tests for true cholinesterase and pseudo-cholinesterase. Biochem. J. 37, 473 (1943).
Mengle, D. C., and O’Brien, R. D., The spontaneous and induced recovery of fly-brain cholinesterase after inhibition by organophosphates. Biochent J. 75, 201 (1960).
Merrill, G. G., Neostigmine toxicity. Report of fatality following diagnostic test for myasthenia. J. Am. Med Assoc. 137, 362 (1948).
Metzger, H. P., and Wilson, I. B., The acceleration of the acetylcholinesterase catalyzed hydrolysis of acetyl fluoride. Biochem. Biophys. Res. Commun. 28, 263 (1967).
Michaelson, I. A., The subcellular distribution of acetylcholine, choline acetyltransferase and acetylcholinesterase in nerve tissue. Ann. N. Y. Acad Sci. 144, 387 (1967).
Michel, H. O., Development of resistance of alkylphosphorylated cholinesterase to reactivation by oximes. Fed. Proc., 17, 275 (1958).
Mitchell, J. F., The spontaneous and evoked release of acetylcholine from the cerebral cortex. J. Physiol. (London) 165, 98 (1963).
Mitchell, J. F., Acetylcholine release from the brain. In “Mechanisms of Release of Biogenic Amines” (U. S. von Euler, S. Rosell, and B. Uvnäs, eds.), p. 425. Pergamon, Oxford, 1966.
Morishima, H. O., Daniel, S. S., Finster, M., Poppers, P. J., and James, L. S., Transmission of mepivacaine hydrochloride (carbocaine) across the human placenta. Anesthesiology 27, 147 ( 1966
Morris, D., and Grewaal, D. S., Isotopic exchange between acetylcholine and [Me-14C] choline catalyzed by human placental choline acetyltransferase. Biochem. J. 114, 85P (1969).
Morris, D., and Grewaal, D. S., Human placental choline acetyltransferase. Eur. J. Biochem. 22, 563 (1971).
Motulsky, A. G., Pharmacogenetics. Prog. Med. Genet. 3, 49 (1964).
Mounter, L. A., Alexander, H. C., and Tuck, K. D., The pH dependence and dissociation constants of esterases and proteases treated with diisopropyl fluorophosphate. J. Biol. Chem. 226, 867 (1957).
Mundell, D. B., Plasma cholinesterase in male and female rats. Nature (London) 153, 557 (1944).
Muralt, A. von, Observations on chemical wave transmission in excited nerve. Proc. R. Soc. London 123, 397 (1937).
Murait, A. von, Lotmar, W., and Wildbrandt, W., Physikalischchemische Messungen an Nervenextrakten. Nachweis einer Aktionssubstanz der Nervenerregung. Proc. Int. Physiol. Congr., 16th2, 924 (1938).
Myers, D. K., Differentiation of three types of competitive cholinesterase inhibitors. Arch. Biochem. 31, 29 (1951).
Myers, D. K., Effect of salt on the hydrolysis of acetylcholine by cholinesterases. Arch. Biochem. 37, 469 (1952).
Nachmansohn, D, Action of ions on choline esterase. Nature (London) 145, 513 (1940).
Nachmansohn, D., “Chemical and Molecular Basis of Nerve Activity.” Academic Press, New York, 1959.
Nachmansohn, D., Choline acetylase. In “Cholinesterases and Anticholinesterase Agents” (G. B. Koelle, ed.), p. 40. Springer-Verlag, Heidelberg, Berlin, New York, 1963.
Nachmansohn, D., Chemical control of the permeability cycle in excitable membranes during activity. Is. J. Med Sci. 1, 1201 (1965).
Nachmansohn, D., Chemical control of the permeability cycle in excitable membranes during electrical activity. Ann. N. Y. Acad Sci. 137, 877 (1966).
Nachmansohn, D., Chemical forces controlling permeability changes of excitable membranes during electrical activity. In “Nerve as a Tissue” (K. Rodahl, ed.), p. 141. Harper (Hoeber), New York, 1966.
Nachmansohn, D., Proteins of excitable membranes. J. Gen. Physiol. 54, 187S (1969).
Nachmansohn, D., and Berman, M., Studies on choline acetylase; on preparation of the coenzyme and its effect on the enzyme. J. Biol. Chem. 165, 551 (1946).
Nachmansohn, D., and Lederer, E., Sur la biochimie de la cholinesterase, préparation de l’enzyme, rôle des groupements-SH. Bull. Soc. Chico. Biol. 21, 797 (1939).
Nachmansohn, D., and Lederer, E., Sur quelques proprietés chimiques de la cholinesterase. C. Seances R. Soc. Biol. Ses. Fil. 130, 321 (1939).
Nachmansohn, D., and Machado, A. L., The formation of acetylcholine. A new enzyme “choline acetylase.” J. Neurophysiol. 6, 397 (1943).
Nachmansohn, D., and Rothenberg, M. A., Studies on cholinesterase. I. On the specificity of the enzyme in nerve tissue: J. Biol. Chem. 158, 653 (1945).
Nachmansohn, D., and Weiss, M. S., Studies on choline acetylase; effect of citric acid J. Biol. Chem. 172, 677 (1948).
Neitlich, H. W., Increased plasma cholinesterase activity and succinylcholine resistance: A genetic variant. J. Clin. Invest. 45, 380 (1966).
Nishi, S., Soeda, H., and Koketsu, K., Release of acetylcholine from sympathetic preganglionic nerve terminals. J. Neurophysiol. 30, 114 (1967).
Nyhan, W. L., Toxicity of drugs in the neonatal period. J. Pediatr. 59, 1 (1961).
Oosterbaan, R. A., Constitution of DFP enzymes. In “Proceedings of the Conference on Structure and Reactions of DFP Sensitive Enzymes” (E. Heilbronn, ed.), p. 25. Swedish Research Institute of National Defence, Stockholm, 1967.
Oosterbaan, R. A., and Jansz, H. S., Cholinesterases, esterases and lipases. Compr. Biochem. 16, 1 (1965).
Oosterbaan, R. A., Jansz, H S, and Cohen, J. A., Studies with 180 on the mechanism of hydrolytic enzyme reactions. Abstr., Int. Congr. Biochem., 5th, Moscow, Aug. 10–16, 1961p. 119 (1963).
Ord, M. G., and Thompson, R. H. S., The distribution of cholinesterase types in mammalian tissues Biochem. J. 46, 346 (1950).
Pantuck, E. J., Ecothiopate iodide eye drops and prolonged response to suxamethonium. Br. J. Anaesth. 38, 406 (1966).
Persson, B. O., Larsson, L., Schuberth, J., and Sörbo, B., 3-bromo-acetonyltrimethylammonium bromide, a choline acetylase inhibitor. Acta Chem. Scand 21, 2283 (1967).
Petty, C. S., Organic phosphate insecticide poisoning. Residual effects in two cases. Am. J. Med 24, 467 (1958).
Plattner, F., Der Nachweis der Vagusstoffes bein Saugetier. Pfluegers Arch. Gesamte Physiol. Menschen Tiere. 214, 112 (1926).
Polak, R. L., An analysis of the stimulating action of atropine on release synthesis of acetyl choline in cortical slices from rat brain. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn, and A. Winter, eds.), p. 323. Försvarets Forskningsanstalt, Stockholm, 1970.
Poppers, P. J., and Finster, M., The use of prilocaine hydrochloride (Citanest) for epidural analgesia in obstetrics. Anesthesiology 29, 1134 (1968).
Potter, L. T., and Glover, V. A. S., Choline acetyltransferase from mammalian brains. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 75. Försvarets Forskningsanstalt, Stockholm, 1970.
Poziomek, E. J., Hackley, B. E., Jr., and Steinberg, G. M., Pyridinium aldoximes. J. Org. Chem. 23, 714 (1958).
Richter, D., and Crossland, J., Variations in acetylcholine content of the brain with physiological state. Am. J. Physiol. 159, 247 (1949).
Robertson, G. S., Serum cholinesterase deficiency. I. Disease and inheritance. Br. J. Anaesth. 38, 355 (1966).
Robins, G. S., Zsigmond, E. K., and Shanor, S. P., Plasma cholinesterase activity and the safe use of succinylcholine in cancer patients. P.esented at the 6th Annu. Meet. Am. Soc. Clin. Pharmacol. Chemother., Atlantic City, May 1–3 (1969).
Rosenberg, P., Kremzner, L. T., McCreery, D., and Willette, R. E., Inhibition of choline acetyltransferase activity in squid giant axon. Biochim. Biophys. Acta 268, 49 (1972).
Rosner, V., Kepes, E. R., and Foldes, F. F., The effects of atropine and neostigmine on heart rate and rhythm. Br. J. Anaesth. 43, 1066 (1971).
Rothenberg, M. A., and Nachmansohn, D., Studies on cholinesterase. III. Purification of the enzyme from electric tissue by fractional ammonium sulfate precipitation. J. Biol. Chem. 168, 223 (1947).
Salpeter, M. M., and Eldefrawi, M. E., Sizes of end plate compartments, densities of acetylcholine receptor and other quantitative aspects of neuromuscular transmission. J. Histochem. Cytochem. 21, 769 (1973).
Sastry, B. V. R., and Henderson, G. I., Kinetic mechanisms of human placental choline acetyltransferase. Biochem. Pharmacol 21, 787 (1972).
Sawyer, C. H., and Everett, J. W., Effects of various hormonal conditions in intact rat on synthesis of serum cholinesterase. Endocrinology 39, 307 (1946).
Sawyer, C. H., and Everett, J. W., Cholinesterases in rat tissues and the site of serum non-specific cholinesterase production. Ant J. Physiol. 148, 675 (1947).
Sawyer, C. H., and Hollinshead, W. H., Cholinesterases in sympathetic fibers and ganglia. J. Neurophysiol. 8, 137 (1945).
Scanlon, J. W., Brown, W. V., Jr., Weiss, J. B., and Alper, M. H., Neurobehavioral responses of newborn infants after maternal epidural anesthesia. Anesthesiology 40, 121 (1974).
Scanlon, J. W., Ostheimer, G. W., Lurie, A.O, Brown, W. V., Jr., Weiss, J. B., and Alper, M. H., Neurobehavioral responses and drug concentrations in newborns after maternal epidural anesthesia with bupivacaine. Anesthesiology 45, 400 (1976).
Schaffer, N. K., May, S. C., and Summerson, W. H., Serine phosphoric acid from diisopropylphosphoryl derivative of sel cholinesterase. J. Biol. Chem. 206, 201 (1954).
Schaner, P. J., Brown, R. L., Kirksey, T. D., Gunther, R. C., Ritchey, C. R., and Gronert, G. A., Succinylcholine-induced hyperkalemia in burned patients. I. Anesth. Analg. (Cleveland) 48, 764 (1969).
Schubert, J., Choline acetyltransf erase; purification and effect of salts on the mechanism of the enzyme catalyzed reaction. Biochim. Biophys. Acta 122, 470 (1966).
Schuberth, J., Sparf, B., and Sundwall, A., A technique for the study of acetylcholine turnover in mouse brain in vivo. J. Neurochem. 16, 695 (1969).
Schuberth, J., Sparf, B., and Sundwall, A., On the turnover of acetylcholine in the brain. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 177. Försvarets Forskningsanstalt, Stockholm, 1970.
Shafai, T., and Cortner, J. A., Human erythrocyte acetylcholinesterase. II. Evidence for the modification of the enzyme by ion-exchange chromatography. Biochim. Biophys. Acta 250, 117 (1971).
Shanor, S. P., Van Hees, G. R., Baart, N., Erdös, E. G., and Foldes, F. F., The influence of age and sex on human plasma-and red cell cholinesterase. Am. J. Med Sci. 242, 357 (1961).
Sharkawi, M., Effects of some centrally acting drugs on acetylcholine synthesis by rat cerebral cortex slices. Br. J. Pharmacol. 46, 473 (1972).
Shen, S. C., Changes in enzymatic patterns during development. In “The Chemical Basis of Development” (W. D. McElroy and B. Glass, eds.), p. 416. Johns Hopkins Press, Baltimore, Maryland, 1958.
Shnider, S. M., Serum cholinesterase activity during pregnancy, labor and puerperium. Anesthesiology 26, 335 (1965).
Shukuya, R., Kinetics of human blood cholinesterase. II. The temperature effect upon cholinesterase activity. J. Biochem. (Tokyo) 40, 135 (1953).
Silver, A., Cholinesterases of the central nervous system with special reference to the cerebellum. Int. Rev. NeurobioL. 10, 57 (1967).
Simpson, N. E. Polyacrylamide electrophoresis used for the detection of C5 + cholinesterase in Canadian caucasians, Indians and Eskimos. Am. J. Hum. Genet. 24, 317 (1972).
Smith, J. C., and Deery, A. M., unpublished data (1966).
Smith, J. C., and Foldes, F. F.; An improved method for the recognition of atypical plasma cholinesterase. Anesthesiology 29, 211 (1968).
Smith, J. C., and Foldes, F. F., The recognition of atypical plasma cholinesterase by relative substrate hydrolysis rate. Biochim. Biophys. Acta 289, 352 (1972).
Smith, J. C., Cavallito, C. J., and Foldes, F. F., The inhibition of choline acetylase (ChA) by bisquaternary ammonium compounds. Fed Proc. 25, 320 (1966).
Smith, J. C., Cavallito, C. J., and Foldes, F. F., Choline acetyltransferase inhibitors: A group of styrylpyridine analogs. Biochem. Pharmacol. 16, 2438 (1967).
Smith, J. C. Foldes, V. M., and Foldes, F. F., Distribution of cholinesterase in normal human muscle. Can. J. Biochem. PhysioL 41, 1713 (1963).
Stedman, E., and Stedman, E., The purification of choline-esterase. Biochem. J. 29, 2563 (1935).
Stefenelli, N., Die Korrelation zwischen dem Albumingehalt und der Cholinesteraseaktivität des Blutserums und ihre Beurteilung bei Albuminverlust. Klin. Wochenschr. 39, 1019 (1961).
Stephenson, M., and Rowatt, E., The production of acetylcholine by a strain of Lactobacillus plantarum. J. Gen. Microbiol. 1, 280 (1947).
Strelitz, F., Studies on cholinesterase. IV. Purification of pseudocholinesterase from horse serum. Biochem. J. 38, 86 (1944).
Surgenor, D. M., and Ellis, D., Preparation and properties of serum and plasma proteins, plasma cholinesterase. J. Am. Chem. Soc. 76, 6049 (1954).
Svensmark, O., Molecular properties of cholinesterases. Acta Physiol. Scand 64, Suppl. 245: (1965).
Svensmark, O., and Heilbronn, E., Electrophoretic mobility of native and neuraminidase-treated horse-serum cholinesterase. Biochim. Biophys. Acta 92, 400 (1964).
Svensmark, O., and Kristensen, P., Isoelectric point of native and sialidase-treated human serum cholinesterase. Biochim. Biophys. Acta 67, 441 (1963).
Swift, M. R., and LaDu, B. N., A rapid screening test for atypical serumcholinesterase. Lancet 1, 513 (1966).
Szentâgothai, J., Einige Bemarkungen zur Struktur der peripheren Endausbreitung regetativer Nerven. Acta Neuroveg. 15, 417 (1957).
Tether, J. E., Echothiopate in treatment of myasthenia gravis. (To be published.)
Thomas, J., and Mather, L. E., The maternal plasma levels and placental transfer of bupivacaine following epidural analgesia. Br. J. Anaesth. 41, 1035 (1969).
Thompson, J. C., and Whittaker, M., Pseudocholinesterase activity in thyroid disease. J. Clin. Pathol. 18, 811 (1965).
Tobias, J. M., Lipton, M. A., and Lepinat, A., Effect of anaesthetic and convulsants on brain acetylcholine content. Proc. Soc. Exp. Biol. Med 61, 51 (1946).
Todrick, A., Fellowes, K. P., and Rutland, J. P., The effect of alcohols on cholinesterase. Biochem. J. 48, 360 (1951).
Tsuji, F. I., Foldes, F. F., and Rhodes, D. H., Jr., The hydrolysis of succinyldicholine chloride in human plasma. Arch. Int. Pharmacodyn. Ther. 104, 146 (1955).
Tucek, S., Subcellular localization of enzymes generating acetyl-CoA and their possible relation to the biosynthesis of acetylcholine. In “Drugs and Cholinergic Mechanisms in the CNS” (E. Heilbronn and A. Winter, eds.), p. 117. Försvarets Forskningsanstalt. Stockholm, 1970.
Usdin, E., Reactions of cholinesterases with substrates, inhibitors and reactivators. In “Anticholinesterase Agents” (A. G. Karczmar, ed.), Int. Encycl. Pharmacol. Ther., Sect. 13, Vol. I, p. 45. Pergamon, Oxford, New York, 1970.
Usdin, E., Mitz, M. A., and Killos, P. J., Studies on the mechanism of action of cholinesterase. Abstr., Int. Congr. Biochem., 6th, 1964Vol. 4, p. 184 (1964).
Van Der Meer, C., Effects of calcium chloride on choline esterase. Nature (London) 171, 78 (1953).
Vicas, I. M., and Sharkawi, M., Synthesis of 14C-acetylcholine by rat cerebral cortex. Proc. Can. Fed. Biol. Soc. 15, 108 (1972).
Vizi, E. S., Kuze, S., and Foldes, F. F., The influence of temperature on neuromuscular transmission in the rat. (To be published.)
Wang, R. I. H., and Ross, C., Prolonged apnea following succinylcholine in cancer patients receiving AB-132. Anesthesiology24, 363 (1963).
Waser, P. G., Receptor localization by autoradiographic techniques. Ann. N. Y. Acad. Sci. 144, 737 (1967).
Webb, E. C., The nomenclature of multiple enzyme forms. Experientia 20, 592 (1964).
Weidemann, H., Die Serumcholinesteraseaktivität beim Leberparenchymschaden. Med Klin. (Munich) 58, 1795 (1963).
Wetstone, H. J., LaMotta, R. V., Middlebrook, L., and White, B. V., Studies of cholinesterase activity. IV. Liver function in pregnancy: Values of certain standard liver function tests in normal pregnancy. Am. J. Obstet. Gynecol. 76, 480 (1958).
White, H. L., and Cavallito, C. J., Photoisomerization of styrylpyridine analogues in relation to choline acetyltransferase and cholinesterase inhibition Biochim. Biophys. Acta 206, 242 (1970).
White, H. L., and Cavallito, C. J., Choline acetyltransferase, enzyme mechanism and mode of inhibition by a styrylpyridine analogue. Biochim. Biophys. Acta 206, 343 (1970).
White, H. L., and Cavallito, C. J., Inhibition of bacterial and mammalian choline acetyltransferases by styrylpyridine analogues. J. Neurochem. 17, 1579 (1970).
White, H. L., and Wu, J. C., Kinetics of choline acetyltransferases (EC 2.3.1.6.) from human and other mammalian central and peripheral nervous tissues. J. Neurochem 20, 297 (1973).
Whittaker, M., The pseudocholinesterase variants: Esterase levels and increased resistance to fluoride. Acta Genet. Stat. Med. 14, 281 (1964).
Whittaker, M., The pseudocholinesterase variants. A study of fourteen families selected via the fluoride resistant phenotype. Acta Genet. Stat. Med 17, 1 (1967).
Whittaker, M., The pseudocholinesterase variants. Differentiation by means of alkyl alcohols. Acta Genet. Stat. Med 18, 325 (1968).
Whittaker, M., Differential inhibition of human serum cholinesterase with n-butyl alcohol: recognition of new phenotypes. Acta Genet. Stat. Med. 18, 335 (1968).
Whittaker, V. P., Specificity, mode of action and distribution of cholinesterases. Physiol. Rev. 31, 312 (1951).
Whittaker, V. P., The binding of neurohormones by subcellular particles of brain tissue. In “Regional Neurochemistry” (S. Kety and J. Elkes, eds.), p. 259. Pergamon, Oxford, 1960.
Whittaker, V. P., Michaelson, I. A., and Kirkland, R. J. A., The separation of synaptic vesicles from nerve-ending particles (synaptosomes). Biochem. J. 90, 293 (1964).
Whittaker, V. P., and Sheridan, M. N., The morphology and acetylcholine content of isolated cerebral cortical synaptic vesicles. J. Neurochem. 12, 363 (1965).
Whittaker, V. P., and Wijesundera, S., The hydrolysis of succinylcholine by cholinesterase. Biochem. J. 52, 475 (1952).
Wills, J. H., Toxicity of anticholinesterases and treatment of poisoning. In “Anti-cholinesterase Agents” (A. G. Karczmar, ed.), Int. Encycl. Pharmacol. Ther., Section 13, Vol. I, p. 355. Pergamon, Oxford, New York, 1970.
Wilson, C. W., Williams, J. P., and Miller, D H, Hazard of cholinergie crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide. Ann. Intern. Med 37, 574 (1952).
Wilson, I. B., Acetylcholinesterase. XI. Reversibility of tetraethyl pyrophosphate inhibition. J. Biol. Chem. 190, 111 (1951).
Wilson, I. B., Bergmann, F., and Nachmansohn, D., Acetylcholinesterase X. Mechanism of the catalysis of acylation reactions. J. Biol. Chem. 186, 781 (1950).
Wilson, I. B., Acetylcholinesterase. XIII. Reactivation of alkyl phosphate-inhibited enzyme. J. Bioi. Chem. 199, 113 (1952).
Wilson, I. B., The active surface of the serum esterase. J. Bioi. Chem. 208, 123 (1954).
Wilson, I. B., The mechanism of enzyme hydrolysis studied with acetyl-cholinesterase. In “The Mechanism of Enzyme Action” (W. D. McElroy and B. Glass, eds.), p. 642. Johns Hopkins Press, Baltimore, Maryland, 1954.
Wilson, I. B., Conformation changes in acetylcholinesterase. Ann. N. Y. Acad Sci. 144, 664 (1967).
Wilson, I. B., and Bergmann, F., Studies on cholinesterase. VII. The active surface of acetylcholine esterase derived from effects of pH on inhibitors. J. Biol. Chem. 185, 479 (1950).
Wilson, I. B., and Bergmann, F, Acetylcholinesterase. VIII. Dissociation constants of the active groups. J. Bioi. Chem. 186, 683 (1950).
Wilson, I. B., and Cabib, E., Acetylcholinesterase: Enthalpies and entropies of activation. J. Am. Chem. Soc. 78, 202 (1956).
Wilson, I. B., and Ginsburg, S., Reactivation of acetylcholinesterase inhibited by alkyl phosphates. Arch. Biochem. Biophys. 54, 569 (1955).
Wilson, I. B., and Quan, C., Acetylcholinesterase studies on molecular complementariness. Arch. Biochem. Biophys. 73, 131 (1958).
Wilson, I. B., Harrison, M. A., and Ginsburg, S., Carbamyl derivatives of acetylcholinesterase. J. Biol. Chem. 236, 1498 (1961).
Winterberg, H., Uber die Wirkung des Physostigmins auf das Warmblüterherz. Z. Exp. Pathol. Ther. 4, 636 (1907).
Wolfers, P., Sensitivity to succinylcholine chloride. Br. Med. J. 2, 778 (1952).
Wolleman, M., “Biochemistry of Brain Tumors” p. 134. Akadémiai Kiadó, Budapest, 1974.
Wolleman, M., and Zoltan, L., Cholinesterase activity of cerebal tumors and tumorous cysts. Arch. Neurol. (Chicago) 6, 161 (1962).
Yoshida, A., and Motulsky, A. G., A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity. Am. J. Hum. Genet. 21, 486 (1969).
Zajicek, J., Studies on the histogenesis of blood platelets. Acta Haematol. 12, 238 (1954).
Zajicek, J., and Datta, N., Investigation on the acetylcholinesterase activity of erythrocytes, platelets and plasma in different animal species. Acta Haematol. 9, 115 (1953).
Zarday, Z., Deery, A., Tellis, I., Soberman, R., and Foldes, F. F., Plasma and red cell cholinesterase activity in uremic patients before and after hemodialysis and after renal transplantation. Abstr. Sci. Pap., Annu. Meet. Am. Soc. Anesthesiol. p. 195 (1973).
Zarday, Z., Deery, A., Tellis, I., Soberman, R., and Foldes, F. F., Plasma and red cell cholinesterase activity in uremic patients.
Zarday, Z., Foldes, F. F., Deery, A. M., and Soberman, R., Butyryl-cholinesterase activity in plasma and urine of nephrotic patients. Clin. Res. 19, 554 (1971).
Zech, R., and Engelhard, H., Acetylcholinesterase-Aktivität im Serum des Elektrischen Aals. Hoppe-Seyler’s Z. Physiol. Chem. 348, 735 (1967).
Zeller, E. A., and Bissegger, N. A., Uber die Cholinesterase des Gehirns und der Erythrocyten. 3. Mitteilung über die Beeinflussung von Fermentreaktionen durch Chemotherapeutica und Pharmaka. Heiu. Chini. Acta 26, 1619 (1943).
Zsigmond, E. K., and Downs, J. R., Plasma cholinesterase activity in newborns and infants. Can. Anaesth. Soc. J. 18, 278 (1971).
Zsigmond, E. K., Pyridostigmine: A safe and effective antagonist to d-tubocurarine in anesthetized man. J. Clin. Pharmacol. Ther. 13, 155 (abstr.) (1972).
Zsigmond, E. K., Foldes, F. F., and Foldes, V. M., The in vitro inhibitory effect of LSD, its congeners and 5-hydroxytryptamine on human cholinesterase. J. Neurochem. 8, 72 (1961).
Zsigmond, E. K., The effect of epinephrine and its congeners on human cholinesterases. Arch. Mt. Pharmacodyn. Ther. 197, 102 (1972).
Zsigmond, E. K., and Robins, G., The effect of a series of anti-cancer drugs on plasma cholinesterase activity. Can. Anaesth. Soc. J. 19, 75 (1972).
Zupaneic, A. O., Anionic centers of cholinesterases as possible cholinoreceptors. Is. J. Med. Sci. 1, 1396 (1965).
Zupaneic, A. O., Evidence for the identity of anionic centers of cholinesterases with cholinoreceptors. Ann. N. Y. Acad. Sci. 144, 689 (1967).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Foldes, F.F. (1978). Enzymes of Acetylcholine Metabolism. In: Foldes, F.F. (eds) Enzymes in Anesthesiology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6248-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6248-0_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6250-3
Online ISBN: 978-1-4612-6248-0
eBook Packages: Springer Book Archive